a public good project by the
Synthesis
Company
of California

© 2026

Eti Alessandra Femia | doi.page

0 works0 citations0 h-index

Eti Alessandra Femia

University of Milan(IT)Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico(IT)

Publications by Year

Research Areas

Platelet Disorders and Treatments, Antiplatelet Therapy and Cardiovascular Diseases, Myeloproliferative Neoplasms: Diagnosis and Treatment, Venous Thromboembolism Diagnosis and Management, Diabetes Treatment and Management

Most-Cited Works

→ Ticagrelor inhibits human platelet aggregation via adenosine in addition to P2Y12 antagonism(2013)148 cited
→ Effect of platelet count on platelet aggregation measured with impedance aggregometry (Multiplate™ analyzer) and with light transmission aggregometry(2013)88 cited
→ Clearance of circulating activated platelets in polycythemia vera and essential thrombocythemia(2011)57 cited
→ Comparison of different procedures to prepare platelet-rich plasma for studies of platelet aggregation by light transmission aggregometry(2011)46 cited
→ Congenital defects of platelet function(2012)44 cited
→ Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome(2019)43 cited

→ Effect of prasugrel in patients with asthma: results of PRINA, a randomized, double‐blind, placebo‐controlled, cross‐over study(2014)

42 cited

→ Inhibition of the platelet P2Y₁₂receptor for adenosine diphosphate does not impair the capacity of platelet to synthesize thromboxane A₂(2015)32 cited

→ Usefulness of the INNOVANCE® PFA P2Y test cartridge for the detection of patients with congenital defects of the platelet P2Y12 receptor for adenosine diphosphate(2013)21 cited

→ Effects of pH and concentration of sodium citrate anticoagulant on platelet aggregation measured by light transmission aggregometry induced by adenosine diphosphate(2017)20 cited